Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
Université de Montréal
$27,000.00
The association between the BDNF Val66Met polymorphism and slow-wave characteristics in older adults with and without mild cognitive impairments.
FY 2025-26
Summary
This study aims to investigate how the BDNF Val66Met polymorphism influences sleep, and especially its deepest stage, in older adults. Slow wave sleep is a deep stage essential for memory consolidation and brain restoration, defined by slow waves (SW) that reflect its depth and quality. Disturbances in sleep have been linked to a higher risk of Alzheimer's disease, which involves progressive cognitive decline, synaptic loss, and brain atrophy. Since these changes can develop years before symptoms appear, identifying early markers is crucial for clarifying risk and guiding prevention. BDNF plays a role in neuronal survival, synaptic plasticity, and sleep regulation. Its activity-dependent secretion can be affected by the Val66Met variant, which may elevate vulnerability to neurodegeneration. However, few studies have examined how this variation relates to SW characteristics in older adults without dementia, including those at higher risk such as individuals with mild cognitive impairment or obstructive sleep apnea. The primary objective is to determine whether the Val66Met polymorphism is associated with sleep, especially SW amplitude, density, and slope in older adults without dementia. A secondary objective is to assess whether plasma BDNF levels vary by genotype and correlate with sleep measures and subjective sleep quality. We hypothesize that Met carriers will show reduced SW characteristics and lower BDNF levels, linked to poorer sleep quality. We will analyze data from 133 adults aged 55 and older, including sleep recordings measuring SW characteristics, questionnaires assessing sleep quality and blood samples quantifying plasma BDNF levels. Clarifying gene–sleep interactions may help identify modifiable risk factors and inform sleep-based prevention strategies.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
572945
Name
Vishnyakova Polina
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The association between the BDNF Val66Met polymorphism and slow-wave characteristics in older adults with and without mild cognitive impairments.
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Alzheimer'S Disease; Bdnf Gene; Genetics; Microarchitecture; Neurodegeneration; Polymorphism Val66met; Polysomnography; Sleep Disturbances; Slow Wave Sleep; Slow Waves
Abstract
This study aims to investigate how the BDNF Val66Met polymorphism influences sleep, and especially its deepest stage, in older adults. Slow wave sleep is a deep stage essential for memory consolidation and brain restoration, defined by slow waves (SW) that reflect its depth and quality. Disturbances in sleep have been linked to a higher risk of Alzheimer's disease, which involves progressive cognitive decline, synaptic loss, and brain atrophy. Since these changes can develop years before symptoms appear, identifying early markers is crucial for clarifying risk and guiding prevention. BDNF plays a role in neuronal survival, synaptic plasticity, and sleep regulation. Its activity-dependent secretion can be affected by the Val66Met variant, which may elevate vulnerability to neurodegeneration. However, few studies have examined how this variation relates to SW characteristics in older adults without dementia, including those at higher risk such as individuals with mild cognitive impairment or obstructive sleep apnea. The primary objective is to determine whether the Val66Met polymorphism is associated with sleep, especially SW amplitude, density, and slope in older adults without dementia. A secondary objective is to assess whether plasma BDNF levels vary by genotype and correlate with sleep measures and subjective sleep quality. We hypothesize that Met carriers will show reduced SW characteristics and lower BDNF levels, linked to poorer sleep quality. We will analyze data from 133 adults aged 55 and older, including sleep recordings measuring SW characteristics, questionnaires assessing sleep quality and blood samples quantifying plasma BDNF levels. Clarifying gene–sleep interactions may help identify modifiable risk factors and inform sleep-based prevention strategies.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Vishnyakova, Polina
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~